702640-95-7 Usage
Uses
Used in Pharmaceutical Industry:
4,7-Dichloro-2-(trifluoromethyl)quinoline serves as a crucial building block in the synthesis of a variety of pharmaceutical drugs and agrochemicals. Its unique chemical structure contributes to the development of novel therapeutic agents and crop protection products.
Used in Antifungal Applications:
4,7-Dichloro-2-(trifluoromethyl)quinoline has been studied for its potential antifungal properties, making it a candidate for use in treatments targeting fungal infections. Its ability to inhibit fungal growth could be leveraged in the development of antifungal medications or in agricultural settings to protect crops from fungal diseases.
Used in Antibacterial Applications:
Additionally, 4,7-Dichloro-2-(trifluoromethyl)quinoline has shown promise in antibacterial research, indicating its potential use in combating bacterial infections. Its incorporation into antibacterial formulations could contribute to the development of new antibiotics or disinfectants to address the growing concern of antibiotic resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 702640-95-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,2,6,4 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 702640-95:
(8*7)+(7*0)+(6*2)+(5*6)+(4*4)+(3*0)+(2*9)+(1*5)=137
137 % 10 = 7
So 702640-95-7 is a valid CAS Registry Number.
702640-95-7Relevant academic research and scientific papers
SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS
-
Page 47-48, (2008/06/13)
Compounds of formula (I) wherein R is hydrogen, lower alkyl, (C3-C8)cycloalkyl, hydroxy, halo, lower alkoxy, trifluoromethoxy, trifluoromethyl or cyano; and A is biaryl, optionally substituted β-naphthyl, bicyclic heterocyclic aryl, (C3-C6)cycloalkylmonocyclic carbocyclic aryl, or (C5 or C6)cycloalkane fused-monocyclic carbocyclic aryl; pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
